ArticleCureus2024
A Comparative Study of Intrathecal Hyperbaric Bupivacaine With Fentanyl Versus Intrathecal Hyperbaric Bupivacaine With Dexmedetomidine Administered Sequentially for Lower Limb Orthopaedic Surgeries: A Prospective Randomised Double-Blind Study.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Comparative effect of bupivacaine local anesthesia with ropivacaine present with fentanyl.Bioinformation · 2025Article
- A randomized comparative study on successional versus premixed intrathecal administration of hyperbaric ropivacaine 0.75% and fentanyl in elective urological surgery.Bioinformation · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe subarachnoid block is the predominant and relatively safe approach during lower limb orthopaedic operations. When used as an additive to intrathecal local anaesthetic, both fentanyl and dexmedetomidine can extend the duration of sensory and motor blockade and improve postoperative analgesia.
objectivesThe objective of this study is to assess and compare the efficacy of sequential administration of fentanyl and dexmedetomidine alongside 0.5% hyperbaric bupivacaine intrathecally in lower limb orthopaedic surgeries, focussing on block characteristics, postoperative analgesia as measured by visual analogue scale (VAS) scores, haemodynamic changes, and adverse effects. MATERIALS AND
methodsSixty patients were randomised into two groups of 30 each. Group A received 15 mg of 0.5% hyperbaric bupivacaine followed by 25 µg of fentanyl, whereas group B received 15 mg of 0.5% hyperbaric bupivacaine followed by 5 µg of dexmedetomidine, administered sequentially for spinal anaesthesia.
resultsPatients in group B exhibited a markedly prolonged sensory and motor block duration compared to group A. The duration required to achieve maximum sensory blockage (T6) was reduced significantly in group B (2.40 ± 0.50 minutes) compared to group A (5.03 ± 0.81 minutes). The average duration of sensory regression to S1 was 207.33 ± 20.18 minutes in group B and 146.57 ± 19.01 minutes in group A (p < 0.001). Patients in group B exhibited a markedly prolonged sensory and motor block duration compared to group A. The duration to attain total motor blockage (Modified Bromage 3) was markedly reduced in group B (4.23 ± 0.68 minutes) relative to group A (7.03 ± 0.81 minutes). The overall analgesic required over a 24-hour period and the average VAS ratings were both lower in group B compared to group A. Additionally, patient satisfaction was higher in group B (207.33 ± 20.18 minutes) than in group A (146.57 ± 19.01 minutes) (p < 0.001).
conclusionThe study concludes that the sequential administration of dexmedetomidine as an adjuvant with the local anaesthetic agent during the subarachnoid block enhances the onset of sensory and motor block, prolongs analgesia, diminishes overall analgesic requirements, increases patient satisfaction, and maintains stable haemodynamics compared to fentanyl. Bradycardia is common with dexmedetomidine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.